Evidence map›Paper›PMID 37874961›Full record

ArticlePerspectives on psychological science : a journal of the Association for Psychological Science2025

Experimental Therapeutics: Opportunities and Challenges Stemming From the National Institute of Mental Health Workshop on Novel Target Discovery and Psychosocial Intervention Development.

Nancy L Zucker, Gregory P Strauss, Joshua M Smyth, K Suzanne Scherf, Melissa A Brotman, Rhonda C Boyd, Jimmy Choi, Maria Davila, Olusola A Ajilore, Faith Gunning and 1 more

Abstract read
In one paragraph

Article in Perspectives on psychological science : a journal of the Association for Psychological Science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Editorial: Mechanism-specific developmental windows of opportunity in the prevention of youth psychopathology.Journal of child psychology and psychiatry, and allied disciplines · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nancy L ZuckerDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0003-2278-5008
Gregory P StraussDepartment of Psychology and Neuroscience, University of Georgia, Athens, Georgia.ORCID 0000-0002-7218-5169
Joshua M SmythDepartment of Psychology, The Ohio State University, Columbus, OH.ORCID 0000-0002-0904-5390
K Suzanne ScherfDepartment of Psychology, Pennsylvania State University, University Park, Pennsylvania.
Melissa A BrotmanNational Institute of Mental Health, Bethesda, Maryland.
Rhonda C BoydDepartment of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Jimmy ChoiOlin Neuropsychiatry Research Center, Hartford Healthcare Behavioral Health Network, Hartford, Connecticut.
Maria DavilaDepartment of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, Chicago, Illinois.
Olusola A AjiloreDepartment of Psychiatry, University of Illinois at Chicago, Chicago, Illinois.
Faith GunningDepartment of Psychiatry, Weill Cornell Medicine, New York, New York.
Julie B SchweitzerDepartment of Psychiatry and Behavioral Sciences and the MIND Institute, University of California, Davis, Sacramento, California.

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
Unit on Neuroscience and Novel TherapeuticsZIAMH002969 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI BROTMAN, MELISSA · 2019 to 2025
$13.8M
Developmental Changes in Neural Processes Underlying Inattention, Impulsivity and RegulationR01MH091068 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SCHWEITZER, JULIE B. · 2012 to 2022
$7.4M
Feeling and Body Investigators (FBI)-ARFID Division: Sensory and Somatic Exposure for Children with Avoidant Restrictive Food Intake DisorderR33MH121549 · NIMH · DUKE UNIVERSITY · PI ZUCKER, NANCY L · 2021 to 2023
$2.2M
Virtual Reality Attention Management Program for Improving Attention in ChildrenR33MH110043 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SCHWEITZER, JULIE B. · 2020 to 2022
$1.8M
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in AutismR33MH110624 · NIMH · PENNSYLVANIA STATE UNIVERSITY, THE · PI SCHERF, KATHRYN SUZANNE · 2018 to 2020
$1.6M
Social Media-Based Parenting Program for Women with Postpartum Depressive SymptomsR61MH118405 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI BOYD, RHONDA C, GUEVARA, JAMES P · 2019 to 2021
$1.5M
Cognitive Training for Emotion Regulation in Psychotic DisordersR61MH121560 · NIMH · UNIVERSITY OF GEORGIA · PI STRAUSS, GREGORY P · 2020 to 2021
$1.2M
Virtual Reality Attention Management Program for Improving Attention in ChildrenR61MH110043 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SCHWEITZER, JULIE B. · 2017 to 2018
$1.1M
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in AutismR61MH110624 · NIMH · PENNSYLVANIA STATE UNIVERSITY, THE · PI SCHERF, KATHRYN SUZANNE · 2016 to 2017
$1.0M
Neurofeedback Processing Speed Training to Improve Social Functioning in Teenagers and Young Adults at Clinical High Risk for PsychosisR33MH111850 · NIMH · HARTFORD HOSPITAL · PI CHOI, JIMMY · 2018 to 2020
$958k
SCH: INT: Computational Tools for Avoidaint/Restrictive Food Intake Disorder R01MH122370 · NIMH · DUKE UNIVERSITY · PI SAPIRO, GUILLERMO R, ZUCKER, NANCY L · 2019 to 2021
$860k
Intramural NIH HHS ZIA MH002969NCATS NIH HHS UL1 TR001860NIMH NIH HHS R01 MH091068NIMH NIH HHS R01 MH122370NIMH NIH HHS R33 MH097959NIMH NIH HHS R33 MH110043NIMH NIH HHS R33 MH110624NIMH NIH HHS R33 MH111850NIMH NIH HHS R33 MH121549NIMH NIH HHS R61 MH110043NIMH NIH HHS R61 MH110624NIMH NIH HHS R61 MH118405NIMH NIH HHS R61 MH121560
6 · The paper itself

Abstract

There has been slow progress in the development of interventions that prevent and/or reduce mental-health morbidity and mortality. The National Institute of Mental Health (NIMH) launched an experimental-therapeutics initiative with the goal of accelerating the development of effective interventions. The emphasis is on interventions designed to engage a target mechanism. A target mechanism is a process (e.g., behavioral, neurobiological) proposed to underlie change in a defined clinical endpoint and through change in which an intervention exerts its effect. This article is based on discussions from an NIMH workshop conducted in February 2020 and subsequent conversations among researchers using this approach. We discuss the components of an experimental-therapeutics approach such as clinical-outcome selection, target definition and measurement, intervention design and selection, and implementation of a team-science strategy. We emphasize the important contributions of different constituencies (e.g., patients, caregivers, providers) in deriving hypotheses about novel target mechanisms. We highlight strategies for target-mechanism identification using published and hypothetical examples. We consider the decision-making dilemmas that arise with different patterns of results in purported mechanisms and clinical outcomes. We end with considerations of the practical challenges of this approach and the implications for future directions of this initiative.

Indexed as

Mental DisordersPsychosocial InterventionHumansNational Institute of Mental Health (U.S.)United Statesexperimental therapeuticsfast failmental healthtarget mechanismtreatment

Identifiers

PMID37874961
PMCPMC11039571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.